Lincoln National Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,477
Closed -$238K 151
2024
Q1
$238K Buy
+3,477
New +$224K ﹤0.01% 1066
2022
Q2
Sell
-12,204
Closed -$541K 868
2022
Q1
$541K Buy
12,204
+2,881
+31% +$125K 0.01% 492
2021
Q4
$396K Buy
9,323
+144
+2% +$6.05K 0.01% 611
2021
Q3
$398K Buy
9,179
+368
+4% +$16.3K 0.01% 576
2021
Q2
$377K Hold
8,811
0.01% 581
2021
Q1
$341K Sell
8,811
-25
-0.3% -$946 0.01% 575
2020
Q4
$318K Buy
+8,836
New +$318K 0.01% 559

Other funds holding BSX

Lincoln National Corp's BSX Position: Q2 2024 in Review

Lincoln National Corp sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 3,477 shares — an estimated $238K sold.

Lincoln National Corp first reported a position in BSX in Q4 2020 and held it in 7 quarters. The position peaked at $541K in Q1 2022. 1,317 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

  • Lincoln National Corp reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 3,477 Boston Scientific shares in Q2 2024, an estimated $238K.
  • Lincoln National Corp first reported a position in Boston Scientific in Q4 2020 and held it in 7 quarters.
  • Lincoln National Corp's Boston Scientific position peaked at $541K in Q1 2022.
  • 1,317 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.